Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Bio-Path Holdings Incorporated third quarter 2024 conference call.
Bio-Path Holdings Inc. (BPTH)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 10,917 | $9,933 | 0% | |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.22 | 7,343 | Director | 160,000 | 2015-07-13 | Filing | |
| $1.17 | 8,724 | Director | 152,657 | 2015-07-09 | Filing | |
| $1.20 | 21,015 | Director | 143,933 | 2015-07-08 | Filing | |
| $1.18 | 38,985 | Director | 122,918 | 2015-07-07 | Filing | |
| $0.30 | 340,000 | Director | 673,334 | 2013-06-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | Large Shareholder | 129,298 | 2019-01-18 | Filing | |
| $0.00 | 0 | Large Shareholder | 129,298 | 2019-01-18 | Filing | |
| $2.66 | 64,457 | Large Shareholder | 129,298 | 2019-01-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,501.45 | $125,023 | 0% | |
| 2. | 5,521.9 | $51,132 | 0% | |
| 3. | 2,735.45 | $25,330 | 0% | |
| 4. | 1,755.95 | $16,260 | 0% | |
| 5. | 1,650 | $15,180 | 0% |
News See All
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q2 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings Second Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q1 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen. Welcome to the Bio-Path Holdings First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Bio-Path Holdings Full Year 2023 Earnings Conference Call. [Operator Instructions] Please also note today’s event is being recorded.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings Second Quarter 2023 Earnings Conference Call.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q1 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2022 Earnings Call Transcript
Operator: Good morning ladies and gentlemen. Welcome to the Bio-Path Holdings Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2022 Earnings Call Transcript
Operator: Good morning ladies and gentlemen. Welcome to the Bio-Path Holdings Third Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode.
Is Bio-Path Holdings, Inc. (BPTH) A Good Stock To Buy?
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...